NEW YORK – Paragon Genomics has developed new target enrichment assays that use its CleanPlex multiplex PCR-based technology, as well as a new technology for gene fusion detection.
The Hayward, California-based company recently launched a cystic fibrosis targeted resequencing assay. It also released the results of collaborations with Admera Health and RareCyte using custom target enrichment kits.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.